Physical activity energy expenditure may mediate the relationship between plasma leptin levels and worsening insulin resistance independently of adiposity

Journal of Applied Physiology

Volumn 102, Issue 5, 2007, Pages 1921-1926

  Franks, P W ^a,b   Loos, R J F ^a   Brage, S ^a   O'Rahilly, S ^c   Wareham, N J ^a   Ekelund, U ^a  

^a MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Energy expenditure; Hyperleptinemia; Prospective cohort study

Indexed keywords

GLUCOSE; INSULIN; LEPTIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; CALORIMETRY; CAUCASIAN; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; HEART RATE; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; UNITED KINGDOM;

ADIPOSITY; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MOTOR ACTIVITY; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 34247855763     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01022.2006     Document Type: Article

References (45)

1. Adage T, Scheurink AJ, de Boer SF, de Vries K, Konsman JP, Kuipers F, Adan RA, Baskin DG, Schwartz MW, van Dijk G. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J Neurosci 21: 3639-3645, 2001.
2. Boden G, Chen X, Kolaczynski JW, Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 100: 1107-1113, 1997.
3. Coppari R, Ichinose M, Lee CE, Pullen AE, Kenny CD, McGovern RA, Tang V, Liu SM, Ludwig T, Chua SC Jr, Lowell BB, Elmquist JK. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 1: 63-72, 2005.
4. Dyck DJ. Leptin sensitivity in skeletal muscle is modulated by diet and exercise. Exerc Sport Sci Rev 33: 189-194, 2005.
5. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 186: 5-16, 2006.
6. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 395: 535-547, 1998.
7. Enriori PJ, Evans AE, Sinnayah P, Cowley MA. Leptin resistance and obesity. Obesity (Silver Spring) 14, Suppl 5: 254S-258S, 2006.
8. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, Jebb SA, Lip GY, O'Rahilly S. Partial leptin deficiency and human adiposity. Nature 414: 34-35, 2001.
9. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110: 1093-1103, 2002.
10. Franks PW, Brage S, Luan J, Ekelund U, Rahman M, Farooqi IS, Halsall I, O'Rahilly S, Wareham NJ. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res 13: 1476-1484, 2005.
11. Franks PW, Farooqi IS, Luan J, Wong MY, Halsall I, O'Rahilly S, Wareham NJ. Does physical activity energy expenditure explain the between-individual variation in plasma leptin concentrations after adjusting for differences in body composition? J Clin Endocrinol Metab 88: 3258-3263, 2003.
12. Franks PW, Luan J, Browne PO, Harding AH, O'Rahilly S, Chatterjee VK, Wareham NJ. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level? Metabolism 53: 11-16, 2004.
13. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 393: 7-20, 2006.
14. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
15. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151: 190-198, 2000.
16. Holtkamp K, Herpertz-Dahlmann B, Mika C, Heer M, Heussen N, Fichter M, Herpertz S, Senf W, Blum WF, Schweiger U, Warnke A, Ballauff A, Remschmidt H, Hebebrand J. Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J Clin Endocrinol Metab 88: 5169-5174, 2003.
17. Hwa JJ, Fawzi AB, Graziano MP, Ghibaudi L, Williams P, Van Heek M, Davis H, Rudinski M, Sybertz E, Strader CD. Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol Regul Integr Comp Physiol 272: R1204-R1209, 1997.
18. Kelley DE, Goodpaster BH. Effects of physical activity on insulin action and glucose tolerance in obesity. Med Sci Sports Exerc 31: S619-S623, 1999.
19. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82: 1293-1300, 1997.
20. Klingberg F, Klengel S. Lesions in four parts of the basal forebrain change basic behaviour in rats. Neuroreport 4: 639-642, 1993.
21. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635, 1996.
22. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 12: 57-65, 1998.
23. Loos RJ, Rankinen T, Tremblay A, Perusse L, Chagnon Y, Bouchard C. Melanocortin-4 receptor gene and physical activity in the Quebec Family Study. Int J Obes 29: 420-428, 2005.
24. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26: 1407-1433, 2002.
25. Marie M, Findlay PA, Thomas L, Adam CL. Daily patterns of plasma leptin in sheep: effects of photoperiod and food intake. J Endocrinol 170: 277-286, 2001.
26. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903-908, 1997.
27. Nagy TR, Gower BA, Shewchuk RM, Goran MI. Serum leptin and energy expenditure in children. J Clin Endocrinol Metab 82: 4149-4153, 1997.
28. Oliveira RL, Ueno M, de Souza CT, Pereira-da-Silva M, Gasparetti AL, Bezzera RM, Alberici LC, Vercesi AE, Saad MJ, Velloso LA. Cold-induced PGC-1alpha expression modulates muscle glucose uptake through an insulin receptor/Akt-independent, AMPK-dependent pathway. Am J Physiol Endocrinol Metab 287: E686-E695, 2004.
29. Patel L, Cooper CD, Quinton ND, Butler GE, Gill MS, Jefferson IG, Kibirige MS, Price DA, Shalet SM, Wales JK, Ross RJ, Clayton PE. Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunction. J Pediatr Endocrinol Metab 15: 963-971, 2002.
30. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
31. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
32. Regensteiner JG, Bauer TA, Reusch JE. Rosiglitazone improves exercise capacity in individuals with type 2 diabetes. Diabetes Care 28: 2877-2883, 2005.
33. Romon M, Lafay L, Bresson JL, Oppert JM, Borys JM, Kettaneh A, Charles MA. Relationships between physical activity and plasma leptin levels in healthy children: the Fleurbaix-Laventie Ville Sante II Study. Int J Obes Relat Metab Disord 28: 1227-1232, 2004.
34. Ruige JB, Dekker JM, Blum WF, Stehouwer CD, Nijpels G, Mooy J, Kostense PJ, Bouter LM, Heine RJ. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care 22: 1097-1104, 1999.
35. Salbe AD, Nicolson M, Ravussin E. Total energy expenditure and the level of physical activity correlate with plasma leptin concentrations in five-year-old children. J Clin Invest 99: 592-595, 1997.
36. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45: 988-991, 1996.
37. Spurr GB, Prentice AM, Murgatroyd PR, Goldberg GR, Reina JC, Christman NT. Energy expenditure from minute-by-minute heart-rate recording: comparison with indirect calorimetry. Am J Clin Nutr 48: 552-559, 1988.
38. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187-E192, 2002.
39. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18: 213-215, 1998.
40. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271, 1995.
41. Tokunaga K, Matsuzawa Y, Fujioka S, Kobatake T, Keno Y, Odaka H, Matsuo T, Tarui S. PVN-lesioned obese rats maintain ambulatory activity and its circadian rhythm. Brain Res Bull 26: 393-396, 1991.
42. Wang MY, Koyama K, Shimabukuro M, Mangelsdorf D, Newgard CB, Unger RH. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc Natl Acad Sci USA 95: 11921-11926, 1998.
43. Wang MY, Koyama K, Shimabukuro M, Newgard CB, Unger RH. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc Natl Acad Sci USA 95: 714-718, 1998.
44. Wareham NJ, Hennings SJ, Byrne CD, Hales CN, Prentice AM, Day NE. A quantitative analysis of the relationship between habitual energy expenditure, fitness and the metabolic cardiovascular syndrome. Br J Nutr 80: 235-241, 1998.
45. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.